All Clarivate Analytics websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.
Oncbiomune Pharmaceuticals Inc., of Baton Rouge, La., said it was advised that about 30 patients have been pre-screened for the phase II/III trial testing prostate cancer vaccine Proscavax in Mexico.
